1 min read
Add as a preferred source on GoogleJohnson & Johnson Reports Positive 30-Day Shockwave Javelin Results
The FORWARD CAD trial evaluated an experimental catheter for severely narrowed coronary arteries that can be difficult to reach with conventional devices.
Johnson & Johnson reported positive results through 30 days from its FORWARD CAD clinical trial on Nov. 1. The study evaluated the company’s experimental Shockwave Javelin catheter.
The catheter is being developed for severely narrowed coronary arteries that conventional devices can have difficulty reaching.
John Kim
John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.